ImageneBio Incorporation
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About ImageneBio Incorporation
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
/ 
Others were interested in
Frequently asked questions
To buy ImageneBio Incorporation stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ImageneBio Incorporation by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ImageneBio Incorporation is IMA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ImageneBio Incorporation has its primary listing on NASDAQ (Small cap). You can trade ImageneBio Incorporation with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ImageneBio Incorporation is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include ImageneBio Incorporation as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like ImageneBio Incorporation.